PGCCs can use IL-6 protein as a paracrine mechanism to facilitate the transformation of fibroblast to more tumor promoting CAFs for chemoresistance, supporting the established role that the TME plays a critical role in tumor development and chemoresistance. The gene discussed is IL6; the disease is neoplasm.